PPGNY

Phosphagenics Ltd.

 
Sponsored ADR (1 ADS : 30 Ordinary) International Reporting
OTCQX International OTCQX Advisor: BNY Mellon
Verified Company Profile 10/04/2016
Contact Info
  • 11 Duerdin Street
  • PO Box 1415 Clayton South 3169
  • Clayton, VIC 3168
  • Australia

Business Description


 
Financial Reporting/Disclosure
Reporting Status International Reporting: ASX - Australian Securities Exchange
Audited Financials Audited
Latest Report Jun 30, 2016 Interim Financial Report
CIK 0001347413
Fiscal Year End 12/31
OTC Marketplace OTCQX International
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o
Incorporated In: Australia
Year of Inc. 1992
Employees 18 a/o Jun 29, 2016
Company Officers/Contacts
Dr. Ross Murdoch CEO, Managing Director
Anna Legg CFO, Company Secretary, Manager
Dr. Paul Gavin Chief Scientific Officer
Margaret Miller Executive Assistant
Company Directors
Peter Lankau Non-Executive Chairman
Service Providers
OTCQX Advisor
BNY Mellon
101 Barclay Street
22nd Floor
New York, NY, 10286
USA

Accounting/Auditing Firm
PricewaterhouseCoopers
Level 19 Freshwater Place
2 Southbank Boulevard
Southbank, VIC, 3006
Australia

Legal Counsel
Not Available
Investor Relations Firm
Not Available
PPGNY Security Details Other Company Securities
Share Structure
Market Value1 $28,612,953 a/o Dec 09, 2016
Authorized Shares Not Available
Outstanding Shares 1,261,965,000 a/o Dec 31, 2015
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Transfer Agent(s)
BNY Mellon
Shareholders
Shareholders of Record Not Available
Non US Stock Exchange Listing
POH - ASX - Australian Securities Exchange - Qualified
Short Selling Data
Short Interest 0 (-100%)
May 31, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security